Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential (a) health benefits and (b) cost savings to the NHS of extending eligibility for the shingles vaccination to immunocompetent people who were aged 65 to 69 before 1 September 2023 and are not currently eligible until they reach the age of 70.

As part of the expansion of the shingles vaccination programme down to adults aged 60 years old, in line with the advice of the Joint Committee on Vaccination and Immunisation, adults turning 65 and 70 years old became eligible for vaccination from 1 September 2023. This phased roll-out was agreed as a means of maximising population benefit and cost-effectiveness, whilst taking account of National Health Service delivery capacity. There are no plans to change this approach to eligibility in advance of 1 September 2028, when the second phase of the expansion will begin, and adults will become eligible for shingles vaccination when they turn 60 and 65 years old.